Free Trial
LON:SENS

Sensyne Health (SENS) Share Price, News & Analysis

Sensyne Health logo

About Sensyne Health Stock (LON:SENS)

Key Stats

Today's Range
N/A
50-Day Range
0.35
0.35
52-Week Range
N/A
Volume
4.45 million shs
Average Volume
3.45 million shs
Market Capitalization
£583,000.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Sensyne Health plc is a healthcare technology company that creates value from accelerating the discovery and development of new medicines and improving patient care through the analysis of real-world evidence from large databases of anonymised patient data in collaboration with NHS Trusts. These anonymised patient data are ethically sourced in that any analysis of anonymised patient data (and hence the Company’s access to it) must be pre-approved for each programme on a case-by-case basis by the relevant NHS Trusts. This is to ensure that the purpose of the anonymisation and the proposed analysis are subject to appropriate ethical oversight and information governance, including conformance with NHS principles, UK data protection law and applicable regulatory guidance. Sensyne Health is an early signatory to the Department of Health and Social Care’s ‘Initial Code of Conduct for data-driven health and care technology’.

Receive SENS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sensyne Health and its competitors with MarketBeat's FREE daily newsletter.

SENS Stock News Headlines

Invest in the AI Boom: Top 5 Stocks to Watch
By now, you're well aware of the artificial intelligence boom. Big Tech has been investing billions of dollars into AI, and the market is projected to grow exponentially. According to several recent reports, the AI market, currently valued at around $100 billion, could grow twenty-fold by 2030 to more than $2 trillion. This explosive growth means it's time to consider these top AI stocks.
Are Health Insurance Premiums Tax-Deductible?
Find The Right Health Insurance For You
See More Headlines

SENS Stock Analysis - Frequently Asked Questions

Shares of SENS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Sensyne Health investors own include bluebird bio (BLUE), BP (BP), Green Plains Partners (GPP), Royal Dutch Shell (RDSB), Artemis Resources (ARV), Athene (ATH) and BELLUS Health (BLU).

Industry, Sector and Symbol

Industry
Health Information Services
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
70
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£7.81 million
Book Value
GBX 20.30 per share

Miscellaneous

Free Float
N/A
Market Cap
£583,000.00
Optionable
Not Optionable
Beta
N/A
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (LON:SENS) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners